Volume 19, Number 9—September 2013
Research
Use of Staged Molecular Analysis to Determine Causes of Unexplained Central Nervous System Infections
Table 3
Pathogen | No. (%) cases |
No. HIV positive | Molecular method | ||
---|---|---|---|---|---|
Total | Meningitis | Encephalitis | |||
Virus | |||||
Enterovirus* | 2 (6) | 2 (8) | 0 | 0 | MassTag PCR |
Human herpesvirus 1 | 2 (6) | 0 | 2 (33) | 0 | MassTag PCR/microarray† |
Human herpesvirus 2 | 1 (3) | 1 (4) | 0 | 0 | MassTag PCR |
Varicella-zoster virus | 3 (10) | 0 | 3 (50) | 0 | MassTag PCR |
Epstein-Barr virus | 16 (52) | 16 (64) | 0 | 9 | MassTag PCR |
Cytomegalovirus |
1 (3) |
0 |
1 (17) |
0 |
MassTag PCR |
Bacteria | |||||
Mycobacterium tuberculosis | 1 (3) | 1 (4) | 0 | 0 | MassTag PCR |
Escherichia coli |
5 (16) |
5 (20) |
0 |
1 |
16S rRNA PCR |
Total | 31 (100) | 25 (100) | 6 (100) | 10 |
*Sequences of enteroviruses showed 1 infection each of echovirus 11 and echovirus 30.
†For 1 case, human herpesvirus 1 was identified by MassTag PCR; in the other, by DNA microarray.
Page created: August 20, 2013
Page updated: August 20, 2013
Page reviewed: August 20, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.